TrialThe Lancet. Child & adolescent health2021

Real-time continuous glucose monitoring in preterm infants (REACT): an international, open-label, randomised controlled trial.

Kathryn Beardsall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.